Dermatomyositis‐like skin eruptions under hydroxyurea therapy conceal TP53 ‐mutated atypical keratinocytes: A histopathologic and molecular pathologic case series
Journal of Cutaneous Pathology · 2024
DOI: 10.1111/cup.14690 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Cutaneous Pathology, 2024. Verfasst von Wiebke Pruessmann und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Lübeck, Lübeck, Germany. Hauptthemen laut MEDLINE: Dermatomyositis, Hydroxyurea, Keratinocytes, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Hydroxyurea is an antimetabolite that inhibits DNA synthesis and is used as a treatment option in chronic myeloproliferative disorders. Rarely, “dermatomyositis (DM)‐like” skin lesions are observed after long‐term therapy. In this case series, five skin biopsies of four patients were evaluated by histology, immunohistochemistry, and next‐generation sequencing of the TP53 gene locus. All biopsies showed focal basal pleomorphic keratinocytes and suprabasal aberrant p53 expression as well as sparse to severe vacuolar interface dermatitis. Histopathologically, “DM‐like” skin lesions can be clearly distinguished from DM by marked subepidermal fibrosis, vascular proliferation, and the absence of dermal mucin deposits. In 75% of the specimens multiple, partly inactivating and/or pathogenic point mutations of TP53 were found in low frequencies. “DM‐like” skin eruptions as a long‐term consequence of hydroxyurea therapy are possibly not chemotherapy‐associated benign toxic changes, but rather inflammatory reactions to complex keratinocyte alterations that clinically mimic the picture of DM. Synergistic mutagenic effects of hydroxyurea and sunlight might be responsible for this unique drug side effect and could provide a pathogenic link to the known increased risk of skin cancer in these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University of Lübeck, Lübeck, Germany.
- Institute of Pathology, University of Lübeck, Lübeck, Germany.
- Dermatopathology Lübeck, Lübeck, Germany.
ORCID-Profile: Wiebke Pruessmann, Christian Rose
Zitieren
APA
Pruessmann, W., Kirfel, J., Sailer, V. W., & Rose, C. (2024). Dermatomyositis‐like skin eruptions under hydroxyurea therapy conceal TP53 ‐mutated atypical keratinocytes: A histopathologic and molecular pathologic case series. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14690
Vancouver
Pruessmann W, Kirfel J, Sailer VW, Rose C. Dermatomyositis‐like skin eruptions under hydroxyurea therapy conceal TP53 ‐mutated atypical keratinocytes: A histopathologic and molecular pathologic case series. Journal of Cutaneous Pathology. 2024. doi:10.1111/cup.14690
BibTeX
@article{Pruessmann2024,
author = {Pruessmann, Wiebke and Kirfel, Jutta and Sailer, Verena-Wilbeth and Rose, Christian},
title = {Dermatomyositis‐like skin eruptions under hydroxyurea therapy conceal TP53 ‐mutated atypical keratinocytes: A histopathologic and molecular pathologic case series},
journal = {Journal of Cutaneous Pathology},
year = {2024},
doi = {10.1111/cup.14690}
}
EUVIMED